Aprea Therapeutics Inc (APRE)
5.61
-0.12
(-2.09%)
USD |
NASDAQ |
Apr 18, 16:00
5.68
+0.07
(+1.25%)
After-Hours: 20:00
Aprea Therapeutics Shareholders Equity (Quarterly): 16.95M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 16.95M |
| September 30, 2023 | 20.29M |
| June 30, 2023 | 23.42M |
| March 31, 2023 | 26.48M |
| December 31, 2022 | 25.64M |
| September 30, 2022 | 26.63M |
| June 30, 2022 | -35.78M |
| March 31, 2022 | 43.59M |
| December 31, 2021 | 49.51M |
| September 30, 2021 | 53.42M |
| Date | Value |
|---|---|
| June 30, 2021 | 60.95M |
| March 31, 2021 | 69.15M |
| December 31, 2020 | 77.40M |
| September 30, 2020 | 89.02M |
| June 30, 2020 | 100.12M |
| March 31, 2020 | 113.35M |
| December 31, 2019 | 124.24M |
| September 30, 2019 | -70.80M |
| June 30, 2019 | 56.34M |
| December 31, 2018 | -51.44M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-70.80M
Minimum
Sep 2019
124.24M
Maximum
Dec 2019
45.79M
Average
49.51M
Median
Dec 2021
Shareholders Equity (Quarterly) Benchmarks
| NeuBase Therapeutics Inc | 9.137M |
| Stoke Therapeutics Inc | 159.56M |
| Processa Pharmaceuticals Inc | 4.989M |
| NovaBay Pharmaceuticals Inc | 3.314M |
| Palatin Technologies Inc | -11.38M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 22.65M |
| Total Liabilities (Quarterly) | 5.697M |